News & AnalysisSynthego rallies $200m Series ESynthego, a genome engineering company, has raised $200 million in Series E financing.ByIris Dorbian17 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsBriefs